Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL B0AT1 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/145804
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a novel B0AT1 inhibitor. The present invention relates to a compound represented by formula (I): (the symbols in the formula are as described in the description) or a salt thereof. The present invention also relates to a B0AT1 inhibitor comprising said compound and a preventive and/or therapeutic agent for amino acid metabolism diseases such as phenylketonuria, hypertyrosinemia (types 1-3), hypermethioninemia, maple syrup urine disease, homocystinuria, non-ketotic hyperglycinemia, propionic acidemia, methylmalonic acidemia, and isovaleric acidemia that contains said compound.

Inventors:
TODOROKI HIDENORI (JP)
SAITO TAKAFUMI (JP)
SHIMOOKA KAZUNARI (JP)
YAMADA TAKAHIRO (JP)
FUKUNAGA KENJI (JP)
KANNO RENTARO (JP)
IMAZU TAKUYA (JP)
Application Number:
PCT/JP2023/002387
Publication Date:
August 03, 2023
Filing Date:
January 26, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MITSUBISHI TANABE PHARMA CORP (JP)
International Classes:
A61K31/165; A61K31/198; A61K31/223; A61K31/341; A61K31/351; A61K31/397; A61K31/40; A61K31/401; A61K31/415; A61K31/4155; A61K31/4162; A61K31/4166; A61K31/4188; A61K31/4245; A61K31/426; A61K31/429; A61K31/437; A61K31/4375; A61K31/44; A61K31/4402; A61K31/4439; A61K31/445; A61K31/454; A61K31/47; A61K31/472; A61K31/495; A61K31/496; A61K31/4985; A61K31/499; A61K31/4995; A61K31/50; A61K31/5025; A61K31/505; A61K31/519; A61K31/5375; A61K31/5383; A61K31/54; A61K31/55; A61K31/551; A61K31/695; A61P3/00; A61P7/00; A61P13/02; A61P43/00; C07C237/22; C07C317/28; C07D205/04; C07D207/12; C07D207/16; C07D207/50; C07D209/30; C07D209/44; C07D211/16; C07D211/46; C07D213/40; C07D213/61; C07D213/68; C07D215/08; C07D217/06; C07D217/14; C07D217/22; C07D217/24; C07D217/26; C07D223/16; C07D231/12; C07D233/38; C07D237/08; C07D239/26; C07D241/04; C07D241/08; C07D241/12; C07D243/08; C07D265/30; C07D271/06; C07D271/10; C07D277/28; C07D295/185; C07D295/205; C07D295/215; C07D307/14; C07D309/04; C07D401/04; C07D403/04; C07D403/06; C07D413/04; C07D413/12; C07D471/04; C07D487/04; C07D487/08; C07D487/10; C07D498/04; C07D513/04; C07F7/18
Domestic Patent References:
WO2020210662A12020-10-15
Foreign References:
JP2013530996A2013-08-01
JP2013530995A2013-08-01
Other References:
SHEFALEE K. BHAVSAR; ZOHREH HOSSEINZADEH; KATJA MERCHES; SHUCHEN GU; STEFAN BRER; FLORIAN LANG;: "Stimulation of the amino acid transporter SLC6A19 by JAK2", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ELSEVIER, AMSTERDAM NL, vol. 414, no. 3, Amsterdam NL , pages 456 - 461, XP028328917, ISSN: 0006-291X, DOI: 10.1016/j.bbrc.2011.09.074
DATABASE REGISTRY ANONYMOUS : " - 2-Propenamide, 3-[4-(4-bromo-1H-pyrazol-1-yl)-3-fluorophenyl]-N-[2-oxo-2- (1-piperidinyl)ethyl]- (CA INDEX NAME) ", XP093082165, retrieved from STN
DANTHI SANJAY J., LIANG BEIRONG, SMICKER OANH, COUPLAND BENJAMIN, GREGORY JILL, GEFTEAS ESTELLE, TIETZ DREW, KLODNITSKY HELEN, RAN: "Identification and Characterization of Inhibitors of a Neutral Amino Acid Transporter, SLC6A19, Using Two Functional Cell-Based Assays", SLAS DISCOVERY: ADVANCING LIFE SCIENCES R&D, MARY ANN LIEBERT, vol. 24, no. 2, 1 February 2019 (2019-02-01), pages 111 - 120, XP093082161, ISSN: 2472-5552, DOI: 10.1177/2472555218794627
Attorney, Agent or Firm:
KAMADA, Mitsunori et al. (JP)
Download PDF: